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ations were obtained between marker ratios of bone metabolism
and change in cartilage volume.
Conclusions: The results of this study suggest that overall, lower
serum levels of bone metabolism in osteoarthritis may be pre-
dictive of cartilage loss. Further insight into understanding how
individual markers of bone metabolism affect cartilage loss may
facilitate understanding of the pathogenesis of this disease and
aid in predicting disease progression
155
THE EFFECTS OF ENDOMEDULLAR IMPLANTS ON THE
PERIOSTEAL VESSEL STRUCTURES OF THE RAT TIBIA
F. Greksa, A. Szabó, K. Wellinger, G. Sohár, M. Boros, K. Tóth
Univ. of Szeged, Szeged, Hungary
Purpose: The healing of bones is successfully achieved after
intramedullar fracture-fusing techniques after fractures or surgery
despite the deﬁnite impairment of peri- and endosteal microcircu-
lation. Prostheses used for surgical treatment of hip osteoarthritis
also impair endosteal circulation. Based on these observations
several authors have proposed that the connection between peri-
and endosteal components of the microcirculation is of minimal
importance in long canaliculated bones. Alternatively, we hypoth-
esized that the reduced efﬁcacy of the endosteal circulation may
be overcome by a compensatory hypertrophy of the periosteal
circulation.
To test this presumption, we intended to answer the following
questions:
1. To what extent does the impairment of the endosteal circulation
modify the density of periosteal vasculature?
2. Is there any impact of drilling the medullar cavity and placement
of intramedullar implant on the density of periosteal circulation?
3. Does the implant material inﬂuence the changes in periosteal
vasculature?
Methods: In female Wistar rats, the medullary cavities of tibias
were drilled out with a series of microdrills (after opening the
proximal metaphyseal cortices of the shin bones) and implants
of different material (polyethylene or titanium) were inﬁxed tightly
into the moulded cavity. Endomedullary vasculature was injured
also by drilling or remained intact in the contralateral tibias. After
a 3-months follow up period, the anteromedial and anterolateral
surfaces of tibial periosteum were exposed under an operating
microscope, and the periosteal microarchitecture was examined
with a Cytoscan A/R-type intravital videomicroscope. Vessel den-
sity of the anteromedial and anterolateral surfaces of tibial pe-
riosteum was evaluated by using an image analyzer computer
software.
Results: Endomedullary drilling (without implants) did not induce
periosteal vascular density changes (total vessel length/examined
area). Higher vascular density was observed in the anterome-
dial and anterolateral periosteum (by 40% and 70%, respectively;
p<0.001) in bones with polyethylene endomedullary implants as
compared to those of the intramedullarly drilled contralateral tib-
ias. With titanium implants, however, the vascular density in the
periosteum was only 20% higher (ns). A moderate, albeit not
signiﬁcant increase in the ratio of larger diameter vessels in the
periosteum was seen in response to endomedullar drilling and
titanium inﬁxing. In polyethylene implants, however, the direction
of changes was opposite as the ratio of large vessels did not
increase, but rather decreased by ∼20%, suggesting the predom-
inance of smaller-diameter vessels in the periosteum.
Conclusions: Surgical damage of the endosteal vessels itself
did not induce signiﬁcant changes in the vascular structure of
the rat periosteum. Placement of endomedullar implants, however,
induces an enhanced vessel formation in the periosteal com-
partment. The quality of the implant has a strong inﬂuence on
these structural changes. Speciﬁcally, polyethylene brings about
a marked increase in periosteal vasular density with a concomi-
tantly increased ratio of small vessels. Our results suggest that the
biologically inert endomedullar titanium causes less pronounced
compensatory vessel hypertrophy in the periosteum as compared
to polyethylene. These results can be linked to the lower osteo-
integrative properties of polyethylene; such material may inhibit
the regeneration of the endosteal vessels which is compensated
by vascular neogenesis reactions of the periosteum.
Supported by research grant OTKA K60752.
156
PIOGLITAZONE, A PEROXISOME
PROLIFERATOR-ACTIVATED RECEPTOR GAMMA AGONIST
REDUCES INFLAMMATORY-INDUCED ALTERATION OF
BONE STRUCTURE IN RAT ADJUVANT POLYARTHRITIS:
EVIDENCE FOR A BONE PROTECTING EFFECT IN
INFLAMMATORY CONDITIONS
M. Koufany1, D. Moulin1, D. Chappard2, M. Muresan3,
P. Netter1, G. Weryha3, J.-Y. Jouzeau1
1Laboratoire de Physiopathologie et Pharmacologie Articulaires,
Vandoeuvre les Nancy, France; 2Laboratoire d’Histologie –
Embryologie, INSERM UMR_S 922, Angers, France; 3Ctr.
Hosp.ier Régional et Univ.ire, Service d’Endocrinologie/Médecine
E, Vandoeuvre les Nancy, France
Purpose: Rheumatoid arthritis is characterized by synovial hy-
perplasia, inﬂammatory inﬁltration, cartilage destruction and juxta-
articular as well as generalized bone demineralization. Since the
discovery of their ability to mediate the pleiotropic effects of
xenobiotics and fatty acid peroxisome proliferators in rodents, per-
oxisome proliferators-activated receptors (PPARs) have emerged
as key regulator of lipid metabolism in humans. PPARs are mem-
bers of the nuclear hormone receptor superfamily which behave
as ligand-activated transcription factors in response to endoge-
nous fatty acids and eicosanoids or isotype-selective synthetic
compounds as ﬁbrates or thiazolidinediones. In this last decade,
increased evidence has shown a role of their three isotypes in
inﬂammatory modulation. We and others demonstrated previously
that PPAR gamma agonists reduced the severity of experimental
polyarthritis and the overall bone loss. In the present study, we in-
vestigated the effect of pioglitazone on inﬂammatory-induced dem-
ineralization and bone microarchitecture in arthritic rats, and the
possible contribution of the osteoclastogenesis mediators RANKL
and IL-17.
Methods: Lewis rats were sensitized by an intra-dermal injection
of 1 mg of complete Freund’s adjuvant (CFA) at the basis of the tail
and were treated orally for 21 days with 30 mg/kg/d pioglitazone, or
with vehicle only. Arthritis severity was evaluated by clinical scor-
ing and histological examination. Bone mineral density (BMD) of
three regions of interest (lumbar spine, right and left femurs) was
measured by dual-energy X-ray absorpsiometry (DEXA) before
sensitization and at day 20. Micro-computed tomography (micro-
CT) analysis of femur was performed to measure mean cortical
height at three different points. Bone volume fraction (BV/TV),
trabecular thickness (Tb.Th), trabecular number (Tb.N) and tra-
becular separation (Tb.Sp) were calculated. Circulating levels of
soluble RANKL, and IL-17 were determined using commercially
available immunoassays.
Results: Treatment with pioglitazone, beyond its ability to reduce
arthritis severity, revealed a major protecting effect on bone ero-
sion, as supported by the histological grading of ankle joints.
Pioglitazone was effective in preventing bone resorption in arthritic
animals as: i) BMD values in all ROIs of treated animals were sig-
niﬁcantly higher compared to BMD values of vehicle-treated con-
trols, ii) femoral cortical bone thickness was preserved markedly
